Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

Similar articles for PubMed (Select 17944916)

1.

The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.

Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):743-8. Epub 2007 Oct 18.

PMID:
17944916
2.

Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.

McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J.

BJOG. 2004 Dec;111(12):1437-43. Erratum in: BJOG. 2004 Dec;111(12):1489.

PMID:
15663132
3.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

4.

The psychosocial burden of human papillomavirus related disease and screening interventions.

Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S.

Sex Transm Infect. 2009 Dec;85(7):508-13. doi: 10.1136/sti.2009.037028. Epub 2009 Aug 24.

PMID:
19703844
5.
6.

'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.

O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, Sharp L; Irish Screening Research Consortium (CERVIVA).

BJOG. 2014 Oct;121(11):1421-9. doi: 10.1111/1471-0528.12741. Epub 2014 Apr 1.

PMID:
24690225
7.

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial.

Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, Sargent A, Peto J; ARTISTIC Trial Study Group.

Br J Cancer. 2006 Jul 3;95(1):56-61. Epub 2006 Jun 13.

8.

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.

Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J; ARTISTIC Trial Study Group.

Health Technol Assess. 2009 Nov;13(51):1-150, iii-iv. doi: 10.3310/hta13510.

9.

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, v Groningen K, Boon ME, Keuning HJ, van Ballegooijen M, van den Brule AJ, Meijer CJ.

Int J Cancer. 2004 May 20;110(1):94-101.

PMID:
15054873
10.

Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.

McCaffery KJ, Irwig L, Turner R, Chan SF, Macaskill P, Lewicka M, Clarke J, Weisberg E, Barratt A.

BMJ. 2010 Feb 23;340:b4491. doi: 10.1136/bmj.b4491.

11.

Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.

Papa D, Moore Simas TA, Reynolds M, Melnitsky H.

J Low Genit Tract Dis. 2009 Apr;13(2):66-71. doi: 10.1097/LGT.0b013e31818a53f0.

PMID:
19387125
12.

Cervical cancer screening, abnormal cytology management, and counseling practices in the United States.

Irwin K, Montaño D, Kasprzyk D, Carlin L, Freeman C, Barnes R, Jain N, Christian J, Wolters C.

Obstet Gynecol. 2006 Aug;108(2):397-409.

PMID:
16880312
13.

Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.

Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C, Griefingholt H, Kovács K, Klozoris C, Bollmann R.

Oncol Rep. 2008 Feb;19(2):457-65.

PMID:
18202795
14.

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3.

Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, Nieminen P.

Eur J Cancer. 2008 Mar;44(4):565-71. doi: 10.1016/j.ejca.2007.12.002. Epub 2008 Jan 8.

PMID:
18248809
15.

Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.

Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, Chan KK, Ngan HY.

Acta Obstet Gynecol Scand. 2011 May;90(5):445-51. doi: 10.1111/j.1600-0412.2011.01092.x. Epub 2011 Mar 16.

PMID:
21306349
16.

Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome.

Cirpan T, Guliyeva A, Onder G, Terek MC, Ozsaran A, Kabasakal Y, Zekioglu O, Yucebilgin S.

Eur J Gynaecol Oncol. 2007;28(4):302-6.

PMID:
17713098
17.

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, Weaver B, Kerndt P, Zenilman J, Hagensee M, Suhr CJ, Weinstock H.

Ann Intern Med. 2008 Apr 1;148(7):493-500.

PMID:
18378945
18.

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, Ho L, Terry G, Sasieni P, Dina R, Soutter WP.

Int J Cancer. 2008 May 15;122(10):2294-300. doi: 10.1002/ijc.23339.

PMID:
18240149
19.

Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.

Oh JK, Franceschi S, Kim BK, Kim JY, Ju YH, Hong EK, Chang YC, Rha SH, Kim HH, Kim JH, Kim CY, Shin HR.

Eur J Cancer Prev. 2009 Feb;18(1):56-61. doi: 10.1097/CEJ.0b013e328305a0a6.

PMID:
19077566
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk